key: cord-0844917-hivcs98j
authors: Cai, G.; Bosse, Y.; Du, M.; Albrecht, H.; Qin, F.; Yu, X.; Luo, X.; Androulakis, M.; Zhu, X.; Zhou, J.; Cui, X.; Yi, C.; Cheng, C.; Nagarkatti, M.; Nagarkatti, P.; Christiani, D.; Whitfield, M.; Amos, C.; Xiao, F.
title: Smoking and SARS-CoV-2 Impair Dendritic Cells and Regulate DC-SIGN Expression in Tissues
date: 2020-12-30
journal: nan
DOI: 10.1101/2020.12.23.20245316
sha: ffa5c01764f3161c59dec87877105a454a704eb9
doc_id: 844917
cord_uid: hivcs98j

The current spreading novel coronavirus SARS-CoV-2 is highly infectious and pathogenic. In this study, we screened the gene expression of three SARS-CoV-2 host receptors (ACE2, DC-SIGN and L-SIGN) and DC status in bulk and single cell transcriptomic datasets of upper airway, lung or blood of smokers, non-smokers and COVID-19 patients. We found smoking increased DC-SIGN gene expression and inhibited DC maturation and its ability of T cell stimulation. In COVID-19, DC-SIGN gene expression was interestingly decreased in lung DCs but increased in blood DCs. Strikingly, DCs shifted from cDCs to pDCs in COVID-19, but the shift was trapped in an immature stage (CD22+ or ANXA1+ DC) with MHCII downregulation in severe cases. This observation indicates that DCs in severe cases stimulate innate immune responses but fail to specifically recognize SARS-CoV-2. Our study provides insights into smoking effect on COVID-19 risk and the profound modulation of DC function in severe COVID-19.

In 2020, a novel coronavirus SARS-CoV-2 has been spreading as a pandemic infection. SARS-CoV-2 is highly infectious and pathogenic through human-to-human transmission and causes severe Coronavirus Disease 2019 (COVID-19) 1 . COVID-19 critical cases are often characterized by a pro-inflammatory "cytokine storm" with a release of excessive cytokines (including IL-6, IL-1, IL-2, IL-10, TNF-a and IFN-g and others) and a hyperactive immune response which cause damage to target organs. Despite extensive research, the exact immune pathophysiology of SARS-CoV-2 has remained elusive.

Coronavirus is a single-stranded RNA virus that can be divided into four main genres including the alpha, beta, gamma and delta coronaviruses 2 . Studies showed that SARS-CoV-2 is closely related to SARS-CoV, with around 80% homology of genome 3 , belonging to the same -genus 4 , having similar receptor-binding domain (RBD) structures 2 and causing similar clinical symptoms including acute respiratory response 5 . Many viruses are capable of using alternative receptors to enter host cells. This is also true for SARS coronavirus. Three receptors-ACE2, DC-SIGN and L-SIGN (gene symbol as ACE2, CD209 and CLEC4M respectively) have been found to be involved in the pathogenicity of SARS-CoV [6] [7] [8] . ACE2 was also been quickly confirmed to be the receptor for SARS-CoV-2 9 . Recently, DC-SIGN and L-SIGN were identified as alternative receptors for mediating SARS-CoV-2 entry into human cells 10 .

In vivo, L-SIGN is largely expressed on endothelial cells in liver sinusoids and lymph nodes, whereas DC-SIGN is mainly expressed on dendritic cells (DCs) 11 . Aside from epithelial cells, SARS-CoV infection was found in T cells, macrophages (Mø) and monocyte-derived dendritic cells and this viral attack is probably responsible for the lymphopenia which was commonly observed in patients with SARS-CoV infection 12 

In the nasopharynx/pharynx samples of 238 patients with acute respiratory illnesses (ARIs), we found ACE2 (P = 3.9 × 10 !"# ) and DC-SIGN ( = 0.048) gene expression were significantly higher with the SARS-CoV-2 infection (Fig. S1 ). In addition, we found ACE2 gene expression was strongly positively associated with the viral load of SARS-CoV-2 ( = 5.3 × 10 !$ ). No data was available for CLEC4M. Notably, the gene expression of essential factors of antigenpresenting cells (APC) for antigen presentation including CD40, CD80 and CD86, HLA genes, IgG immunoglobulin receptor (FcR) III and interferon-gamma (IFN-g) were upregulated in SARS-CoV-2 ARIs compared to non-viral ARIs, whereas IgA and IgE FcRs, interferon-kappa (IFN-k), and cyclooxygenase (COX) genes PTGS1 and ALOS5 were downregulated. The gene expression of ACE2, CD80, CD86, CD83, IFN-g, FCER1G and IgG FcRs were increasingly associated with the viral load of SARS-CoV-2 (Fig. 1A, Fig. S1 ). No such association were observed in HLA genes. In addition, the proportions of activated CD4 + memory T cells (CD4m T) and M1 Mø were increased in SARS-CoV-2 ARIs and significantly associated with increased viral load (Fig. 1A, Fig. S1 

We investigated the association of the expression of ACE2, DC-SIGN and L-SIGN with COVID-19 risk by large-scale population genetic association analyses (see Methods). Using Mendelian Randomization (MR), we found that the expression of DC-SIGN plasma protein were associated with increased COVID-19 risk ( = −0.14, = 3.39 × 10 !' ) and severity ( = −0.30, = 5.41 × 10 !& ; Table S1 ). Such significant associations were not found in ACE2 and L-SIGN.

The important role of DC-SIGN in phagocytosis and immune activation was also reflected by the phenotype associations detected in this study. GWAS found that the genetic variation of CD209 is associated with multiple diseases, including asthma (the top among detected associations, = 1.0 × 10 !"' ), cancers and neurological disorders (Table S2) CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint percentage: = 0.03, = 8.52 × 10 !' ; Table S4 ). Moreover, we also observed such significant associations of CD209 expression with immune cell composition in blood samples of 160 ARDS cases and 142 non-ARDS controls, regardless of the disease status (Fig. S2 ). In addition, we found that CD209 expression was associated with immune related symptoms such as tiredness or low energy, depression and duration of fitness (Table S3 ). In lung adenocarcinoma tumors, we only observed a slight downregulation of CD209 ( = −0.26, = 0.07) and no significant association with survival ( = 0.33) and tumor stage ( = 0.80).

We previously have found that smoking upregulates the lung expression of ACE2 18 . In this study, we further investigated the effect of smoking on expression of CD209 and CLEC4M from 8 independent studies (N=1162). Adjusted for age and sex, CD209 expression was significantly upregulated in smoker lungs (meta-analysis = 0.15, = 1.1 × 10 !$ , Fig. 2A ). Significant association (meta-analysis = 0.1, = 0.03) between CD209 expression and smoking status (never-, former-and current-smoker) was also observed with 4 out of 5 available datasets showing a positive trend of association ( Fig. 2A) . We did not find a significant difference in CLEC4M gene expression (Fig. S3 ).

We next investigated the dysregulation of ACE2, CD209 and CLEC4M in specific types of cells in normal airway samples of never-smokers and ever-smokers. Cell types were identified from scRNA-seq datasets of bronchial epithelium (GSE131391) and lung tissues (GSE122960 and Madissoon) using known markers (Fig. S4, Fig. S5 ). We found that ACE2 was mainly expressed in pneumocytes, secretory cells, ciliated cells, never-smokers' club cells and smokers' goblet cells (Fig. 2B) , which was consistent with the recent study of Ziegler et al. 23 and our pervious observation 18 . Compared to never-smokers, we found higher detection rate of ACE2 in ciliated cells in ever-smokers in both lung datasets. The GSE122960 dataset also showed higher expression of ACE2 in AT1 and fibroblast cells by smoking. Active expression of CD209 was found in lung DCs, Mø and monocytes (Fig. 2B ). Compared to non-smokers, eversmokers showed increased CD209 expression in lung DCs (GSE122960 P < 0.01 and Madissoon P < 0.01). Higher CD209 expression was also found in Mø of ever-smokers in the dataset of GSE122960 (P < 0.001). The expression of CLEC4M was only notably detected in lung vessel epithelial cells and no significant smoking effect was observed.

Further, we investigated smoking effect on gene methylation of CD209 and ACE2 by comparing DNA methylation data from smoker and non-smoker lungs in 5 studies (N = 242).

Adjusted by age and sex, an overall decrease of methylation was detected across CD209 in smokers, including two significant loci (cg01618851, cg07608333) by meta-analysis and two significant loci (cg04015765, cg21848746) in the GSE133062 study (Fig. 2C ). Although not significant with limited sample size, loci cg01618851 and cg07608333 showed trends of negative correlation between CD209 gene expression and methylation (Fig. 2C) . No data was available to investigate the expression-methylation association for loci cg04015765 and cg21848746. In addition, no significant association was observed in ACE2 (Fig. S6 ).

To verify whether smoking affects the composition of immune cells in lung, we assessed immune cell proportions in normal lung tissues from the above 8 independent bulk transcriptomics studies and evaluated their associations with smoking by meta-analysis. Among 22 immune cell types, we found that resting DCs, CD8 + T cells, and activated CD4m T cells were augmented while resting CD4m T cells, activated NK cells, M1 Mø, eosinophils and neutrophils were depleted in lungs of smokers (Fig. 3A left) . A similar pattern of associations with smoking history (never, former or current smoker) was observed, with significant positive correlation for CD8 T cells and follicular helper T cells, and negative correlation for CD4 memory resting T cells, activated NK cells, eosinophils and neutrophils (Fig. 3A right) . In addition, both . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint resting and activated DCs showed trends of positive association with the smoking history. A trend of increase of DC proportion in smokers was also found in scRNA-seq datasets (Fig. S7 ).

Further, we investigated whether smoking affects the maturation of DCs by examining the gene expression of the maturation marker CD83 and the T-cell stimulatory molecules CD86, CD80 and CD40 in the GSE122960 and Madissoon scRNA-seq datasets (Fig. 3B ). In DCs of ever-smoker lungs, we found a significant downregulation of CD83 in both datasets. In the Madissoon dataset, we also found significantly lowered expression of CD40 and CD80. These 

We next systematically investigated the cell type-specific expression of CD209 in upper airway, lower airway and peripheral blood by analyzing scRNA-seq datasets from one patients and healthy controls. Cell types were identified in each dataset (Fig. S8) , and the detection rates and average expression of ACE2, CD209 and CLEC4M were compared between groups (Fig. 4A ). Compared to healthy controls, patients with mild and severe disease showed higher detection rates of ACE2 in the nasopharynx/pharynx secretory, ciliated, and . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint pulmonary epithelial cells. No notable expression of CLEC4M was observed in any cell type in any of the four datasets.

Notable expression of CD209 was found in DCs, airway Mø and blood monocytes (Fig. 4A) .

Significantly, we found that CD209 expression in lung monocyte-derived macrophages (MoD Mø) and blood classical (CD16or CD14 + ) monocytes was severity-dependently decreased in COVID-19, while CD16 + monocytes showed a severity-dependent increase of CD209 expression in the dataset of Wilk et al. In DCs, CD209 expression was decreased in lungs but increased in blood of COVID-19 cases, as compared to healthy controls. With a small number of detected DCs (N = 12), the Lee PBMC dataset didn't detect such increase in severe COVID-19

cases. The discrepancy among anatomical sites were also found in the alteration of the DC proportion among white blood cells (WBC) (Fig. 4B ). In airway samples, the proportion of DCs was increased in mild cases and decreased in severe cases. A decrease was also found in severe cases in blood, but no notable change was observed in mild cases. Inversely to DCs, the proportions of MoD Mø and monocytes were increased in severe cases in all three tissues. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint Leishmania infection and others) were activated in mild cases as compared to healthy control but interestingly were inhibited in severe cases as compared to mild cases. Such pattern was also observed on antigen processing and presentation, host metabolism as well as DNA replication in lung but not in blood. Correspondingly, immune initiation related genes (including CD1A, CD1C, CD1E, CCL17, FCER1A, FCGR2B and others) and ribosome genes were significantly downregulated in severe COVID-19 cases as compared to healthy controls, whereas inflammatory signals (including interferon genes, CCL2, CCL4, CCL8 and others) were upregulated (Fig. 5C ). Compared to mild cases, chemokines (including CCL2, CCL4, CCL8) and MAPK substrates (including JUN, USF1, FOS) were upregulated in severe cases, whereas antigen presentation related genes (HLA-DQA2, C1QC and C1QA) were downregulated.

Interestingly in blood, we also found neural disease related pathways were severity-dependently activated and cancer related pathways were inhibited in severe cases ( (Fig. 6B ). Compared to mild cases, severe cases showed decreased . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint MHCII expression in airway APCs but not significantly in blood. The result was in agreement with above pathway analysis that antigen processing and presentation were activated in mild cases but inhibited specifically in lungs of severe cases. Significantly in lung and blood APCs, HLA-DQA2 expression were increased in mild cases as compared to healthy controls but downregulated in severe cases as compared to mild cases. Interestingly, compared to healthy controls, the global change of MHCII and FcRs gene expression in blood were associated with COVID-19 severity, with upregulation in asymptomatic cases, no significant change in mild cases and downregulation in severe cases (Fig. S9 ).

Together, these observations indicate the ability of DCs for T-cell stimulation is induced but the maturation of DCs is inhibited in both lung and blood of severe COVID-19, and specifically the antigen presentation ability of APCs is reduced in lung, which is the primary site of infection.

We further investigated the variation of DC subsets in nasopharynx/pharynx, BALF and PBMC samples from COVID-19 patients and healthy controls. Based on known markers (Fig. S10 ), four DC subsets were identified in the nasopharynx/pharynx samples, including type I and II conventional dendritic cells (cDC1 and cDC2), Mø-like DC which expressed Mø markers S100A8 and S100A9, Plasmacytoid dendritic cell (pDC) and a new subset of CD22 + ITM2C + DC; seven subsets were identified in the BALF samples, including cDC1, cDC2, mature cDC2, Mølike DC, pDC and new subsets CD22 + DC and ANXA1 + DC; four subsets were identified in the PBMC samples from the Lee dataset, including cDC1, cDC2, mature cDC2 and Mø-like DC;

four subsets were identified in the PBMC samples from the Wilk dataset, including cDC1, cDC2, mature cDC2 and Mø-like DC (Fig. 7A ). The integration of all datasets found that these subsets were conservative among tissues (Fig. S11 ). CD22 + ITM2C + DC in nasopharynx/pharynx samples were clustered together with CD22 + DC in BALF samples, which were characterized by . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Among DCs, the proportion of cDC2 was severity-dependently decreased in both lung and blood of COVID-19 (Fig. 7B) . Inversely, the mature cDC2 was increasingly correlated with disease severity in lung BALF samples. Such increase was also found in PBMC with mild COVID-19 but not in severe cases which might be due to its limited cell detection of DC cells (Fig. S12 ). In addition, we found the BALF specific ANXA1 + DC subset showed high expression of COX related genes PTGS1, PTGS2, HPGDS, ALOX5 and LTC4S, which may be responsible for the DC immunity suppression 24 , together with ANXA1 25 .

We observed a clear shift from conventional DCs to pDC on single cell trajectory in COVID-19 BALF and PBMC, in response to viral infection (Fig. 7C) . However, the shift was trapped in the path in severe cases, producing immature subsets. The blockade was also observed in nasopharynx/pharynx with severe COVID-19 (Fig. S13 ). Further we found that both bursting frequency and size of MCHII genes were inhibited in the lung specific immature subset ANXA1 + DC as compared to cDC2 and pDC (Fig. S14 ). Increased frequency and size of Cox genes were also observed. This indicate the SARS-CoV-2 infection may inhibit the DC maturation by . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint regulating the expression kinetics parameters (bursting frequency and bursting size) of related genes. Indeed, the activated neutrophils produce TNF-alpha and induce DC maturation which lower the CD209 expression 26 ; CD209 mediates the activation of T cells 27 . The neutrophil-to-lymphocyte ratio has been studied as a severity marker in COVID-19 28 and as a valid prognostic factor in various solid tumors and other chronic diseases 29 . Therefore, the interaction of CD209 and DCs with neutrophils and T cells may play an important role in mediating cytokine storm coupled with limited anti-viral capability, which are keys in COVID-19 pathogenesis 30 . Further investigation is required to elucidate this interaction and the causal effect of ACE2 or CD209 to the COVID-19 risk.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. showed upregulation of T cell stimulation but downregulation of antigen presentation and maturation, indicating that DCs may stimulate innate immune system but fail to recognize SARS-CoV-2. This may lead to the negatively correlated cytotoxic follicular helper response with antibody levels to SARS-CoV-2 spike protein in hospitalized COVID-19 patients 31 . SARS-CoV-2 might use an escape mechanism similar to HIV-1 which hides in DCs and uses DC-SIGN as a trans-receptor for efficient transmission to T cells, and also similar to Mycobacteria tuberculosis (M. tb) which subverts DCs by targeting DC-SIGN and inhibiting maturation 32 . The stimulated and "blinded" immune systems could be responsible for the cytokine storm as well as severe ARDS suffering COVID-19 critical cases. MHCII genes especially HLA-DQA2 might be involved in this pathogenesis, which were found to be decreased in lung of severe cases compared to mild cases. This may also link to the olfactory impairment which is often seen in patients with COVID-19, given that MHC are essential in individual olfactory perception 33 .

The observed broad downregulation of MHCII genes in APCs was aligned with recent findings that dysfunctional monocytes 34, 35 and B cells 36 in severe COVID-19. Here, we report a shift from cDCs to pDCs in COVID-19 cases, which leads to the marked disease severity-. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint dependent depletion of cDC2 in all studied tissues. Strikingly, the shift was blocked in immature subsets including CD22 + DC and ANXA1 + DC with suppressed activation markers. This immunosuppression of DCs may contribute to the variation of disease severity through the interactions between DCs and T cells and other immune cells. Indeed, we found the immature subtype CD22 + ITM2C + DC was significantly positively correlated with the resting subsets of Mø, CD4mT and mast cells in upper airway.

In this study, we also investigated the smoking effect on respiratory gene expression of these three receptors of both SARS-CoV and SARS-CoV-2. We found ever-smokers had significantly higher ACE2 and CD209 gene expression than non-smokers, respectively in lung . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ;  Collectively, this study provides important pieces of puzzle of COVID-19 about dysfunctional DC cells from the expression of receptors of SARS coronavirus, the effect and potential risk of smoking, and remodeling of DC activation and redistribution of DC subsets.

Although further studies with a larger sample size of single cell or single cell type studies will be needed to properly assess this matter, this study provide important hints for vaccine development, as well as the variation of COVID-19 severity and pathogenesis. 

CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint 

We studied the metagenomic next generation sequencing (mNGS) data of nasopharynx/pharynx samples from 197 patients with acute respiratory illnesses, including 94 patients confirmed with SARS-CoV-2 infection by clinical PCR and 103 with no virus detected 42 .

The host gene expression read counts and the CPM (read counts for million) of SARS-CoV-2 virus were analyzed. We normalized the read counts of ACE2 and CD209 using the TMM method and calculated CPM using edgeR 58 . The data for CLEC4M was not available.

We deconvoluted the immune cell composition from these bulk RNA-seq data using is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint activated), eosinophils and neutrophils. Using transcriptome profiles of DC subsets identified in below scRNA-seq datasets of nasopharynx/pharynx samples, we also estimated the composition of DC subsets in these bulk RNA-seq data using MuSiC 59 .

Linear regression was used to test the difference of gene expression or immune cell proportions between sample groups as well as their association with SARS-CoV-2 viral load in samples. was used to perform whole-transcriptome differential expression analysis from raw counts.

We analyzed three single-cell RNA sequencing datasets including GSE131391 66 , GSE122960 67 and a dataset from Madissoon et al. 68 . The GSE131391 dataset focused on bronchial epithelial . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint cells, ALCAM+ epithelial cells and CD45+ white blood cells from 6 never-and 6 currentsmokers. The GSE122960 dataset was from lung tissues of 8 lung transplant donors, including 5 never-and 3 ever-smokers. The Madissoon dataset was from lung tissues of 4 never-and 3 ever-smokers. Sequencing read counts in single cells were downloaded, and subsequent data analyses were performed using the Seurat 3.0 package 69 , including data normalization, high variable feature selection, data scaling, dimension reduction and cluster identification. The

Louvain method was used on the top 20 principle components to identify clusters, which were visualized in reduced dimensions of Uniform Manifold Approximation and Projection (UMAP).

Cell types were assigned to clusters based on markers used in each original study. In 

We investigated the gene expression of ACE2, CD209 and CLEC4M in scRNA-seq datasets of nasopharynx/pharynx, BALF and PBMC samples from COVID-19 patients and healthy controls.

The nasopharynx/pharynx data were available in the study of Chua et al. 43 with the count matrix and cell type identification derived from 11 moderate and 8 critical COVID-19 patients and 5 healthy controls. We also downloaded the count data of BALF samples from 6 severe and 3 mild COVID-19 patients as well as 3 healthy controls from GEO GSE145926 15 . Also, the count . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint data from PBMC samples of 6 severe, 4 mild, and 1 asymptomatic COVID-19 patients and 4 healthy controls were downloaded from GEO GSE149689 of Lee et al. 70 . In addition, we analyzed another PBMC scRNA-seq dataset from the study of Wilk et al. 44 , which was from 6 healthy controls and 7 COVID-19 patients. 4 of 8 COVID-19 samples were collected from patients who were diagnosed with ARDS and were ventilated. Two samples were collected from one patient in the non-severe condition without ventilation and in the severe condition with ventilation.

scRNA-seq data processing was performed using Seurat with steps same as above. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint identified activated granulocytes (Act granulocytes), B cells, CD14 + monocytes, CD16 + Multivariate linear regressions were used to test the association of the M-values of CD209 methylation probes with smoking status adjusted for sex and age. Using the effect size and . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint standard error estimates from each study, a random-effects meta-analysis was performed as described before. With paired data from the GSE32863 73 mRNA expression and the GSE32861 methylation measurements, we also evaluated the correlation of CD209 expression abundance and methylation level in 58 paired samples.

Linear regression was used to evaluate the association between variables and perform twogroup comparison. To evaluate the association of CD209 expression with tumor stage and survival of lung adenocarcinoma tumors, ordinal regression and Cox proportional hazard model were used respectively.

Pathway and network analyses were performed to systematically investigate biological processes involved in smoking or COVID-19. We calculated transcriptome-wide fold changes (FC) of expression and ranked the differential expression according to log2FC. For Based on these ranks, preranked Gene Set Enrichment Analysis (GSEA) 77 

To infer the bursting kinetics from single cell transcriptomic data, we developed a Bayesian hierarchical framework to estimate the bursting kinetic parameters (i.e. transcribe rate , . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We also formulated a differential bursting analysis framework that can further explored the change in bursting kinetics between different study conditions. After applying the MCMC method, the MCMC samples provided various representative combinations of bursting frequency and size values, while the credible differences of bursting frequency and size could be examined by computing and summarizing the changes at each combination of parameters values. Those credible differences could then be used to assess the credibility of "null value" 85 .

We applied the proposed method to investigate the differences of bursting kinetics in ANXA1 + DCs in COVID-19 lung compared to pDCs and cDC2s separately. With the processed scRNA-. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted December 30, 2020. ;  seq count data generated from previous pipeline, changes in bursting frequency and size estimates (in log2 scale) were computed.

We utilized public resources to search for CD209 related traits/disease candidate.

PhenoScanncer 86 was used to obtain associated phenotypes from genome-wide association study (GWAS) studies. Also, PhenomeXcan 87 underlying phenome-wide association study (PheWAS) analytic framework was used to infer associations of CD209 lung expression and multiple traits, by integrating GWAS summary statistics of 4,091 traits and Genotype-Tissue Expression data from GTEx 88 lung tissue version 8.

Mendelian Randomization (MR) analysis provides evidence for a causal relationship between exposure and outcome. To infer the causal effect of plasma expression of ACE2 and DC-SIGN on COVID-19 risk and severity, we applied the TwoSampleMR R package 89 for MR analysis.

For exposures of protein expression of SARS-CoV-2 receptors, we obtained publicly available plasma protein QTL summary statistics from the study of Sun et al. 45 . For outcomes of COVID-19 risk and severity, we separately required GWAS summary statistics from GRASP (https://grasp.nhlbi.nih.gov/COVID-19GWASResults.aspx; files with name "ALLwhites" at 06-05-2020) for COVID-19 risk, and that from the study of Ellinghaus et al. 46 for COVID-19 severity.

Independent genetic instruments of exposures were selected for MR analysis based on strict criteria of minor allele frequency (MAF) > 0.05, linkage disequilibrium (LD) r 2 < 0.01 within a clumping window of 10,000 kb, and beyond genome-wide significance (P < 5×10 -8 ). As there were no genetic instruments of plasma ACE2, the significance threshold for selecting instruments was set as P < 10 -4 . Ultimately, we found 3, 60, and 1 SNPs as independent genetic instruments for plasma CD209, ACE2, and CLEC4M, respectively. Inverse-variance-weighted . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint (IVW), weighted median, and MR-Egger regression methods were used to calculate effect size ( ) and corresponding standard error (SE). The Wald ratio method was used if only one genetic instrument remained. Heterogeneity was estimated using MR-Egger and IVW methods.

Directional pleiotropy was estimated via MR-Egger intercept test.

All data management, statistical analyses and visualizations were accomplished using R software version 4.0.2.

The data derived from MEARDS was accessible upon request to Dr. David C. Christiani (dchris@hsph.harvard.edu). Data from other studies were openly available to the public without registration or application for access. Processed single cell transcriptomics data were available for visualization and exploration in SCANNER 48 (https://www.thecailab.com/scanner/). The hosted data include three datasets from the normal airway samples from ever-smokers and non-smokers, as well as four datasets from the DCs of nasopharynx/pharynx, BULF and PBMC samples from COVID-19 patients and healthy people.

All the data were de-identified and study approval has been stated in original studies. The

General Hospital (MGH) and Harvard School of Public Health (project approval number: 1999P0086071/MGH).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint

The top panel shows a comparison of ever-smokers (including current and former smokers) and nonsmokers, and the bottom panel shows the association of CD209 gene expression with smoking status (never, former, or current smoker). For each study, pooled effect size, 95% CI and P values were calculated by meta-analysis. The size of the squares is proportional to the weights, which were estimated by the standard "inverse-variance" method for random-effects models in meta-analysis. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint blue * indicates lower expression in severe cases compared to mild cases, in severe cases compared to healthy controls, in mild cases compared to healthy controls, in severe cases compared to asymptomatic cases, in mild cases compared to asymptomatic cases, or in asymptomatic cases compared to healthy controls.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. For each cell type, the top panel shows a comparison of ever-smoker (including current and former smokers) and nonsmoker groups, and the bottom panel shows the association of the gene expression with smoking status (never, former, or current smoker). For each study, the estimated effect size and 95% confidence intervals (CIs) are plotted. The size of the squares is proportional to the weights, which were estimated by the standard "inverse-variance" method for random-effects models in meta-analysis.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint Figure S4 . Clusters of single-cell transcriptomics of bronchial epithelium and lung cells.

For each dataset, the left shows UMAP embedding of single-cell transcriptome profiles from never smokers and current or ever smokers. The right shows identified cell types.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint Figure S5 . Expression profiles of cell type markers in scRNA-seq data of bronchial epithelium and lung cells.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint For each marker, detection rate (showed by dot size, larger dot indicates higher detection rate) and expression level (showed by dot color which is status specific, darker indicates higher expression level) are shown in identified cell types. For each probe, pooled effect size, 95% CI and P values were calculated by meta-analysis from available studies, including a: TCGA, b: GSE32861, c: GSE133062, d: GSE92511 and e: GSE139032. For each study, the estimated effect size and 95% confidence intervals (CIs) are plotted. The size of the squares is proportional to the weights, which were estimated by the standard "inverse-variance" method for random-effects models in meta-analysis.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint Figure S8 . Clusters of single-cell transcriptomics of nasopharynx/pharynx, BALF and

For each dataset, the left shows UMAP embedding of single-cell transcriptome profiles from COVID-19 mild and severe cases, and healthy controls. The right shows identified cell types. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint type, red indicates relatively higher proportion and blue indicates relatively higher proportion across samples. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Spearman correlation coefficients for expression of each pair of genes were shown in boxplot.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint Table S1 . Mendelian Randomization inferred causal effect of plasma expression of ACE2, . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint Table S3 . The top 100 CD209 lung expression associated traits identified by PheWAS.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint 

This work was supported by University of South Carolina COVID-19 research initiative (G.C.). 

The authors declare no competing interests.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.23.20245316 doi: medRxiv preprint

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Coronaviruses: an overview of their replication and pathogenesis

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus

A pneumonia outbreak associated with a new coronavirus of probable bat origin

CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells

L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus

The trinity of COVID-19: immunity, inflammation and intervention

DC-SIGN and L-SIGN: the SIGNs for infection

Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Clinical Characteristics of Coronavirus Disease 2019 in China

Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2

Neurological associations of COVID-19

Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review

Cerebrospinal fluid dendritic cells infiltrate the brain parenchyma and target the cervical lymph nodes under neuroinflammatory conditions

Cranial neuropathies and COVID-19: Neurotropism and autoimmunity

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

Tumor cyclooxygenase 2-dependent suppression of dendritic cell function

Annexin-1-deficient dendritic cells acquire a mature phenotype during differentiation

Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN

The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells

Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis

A glimpse into the eye of the COVID-19 cytokine storm

Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4 T cells in COVID-19

DC-SIGN: escape mechanism for pathogens

Major histocompatibility complex peptide ligands as olfactory cues in human body odour assessment

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

The Loss of Bcl-6 Expressing T Follicular Helper Cells and the Absence of Germinal Centers in COVID-19

Epigenotype switching at the CD14 and CD209 genes during differentiation of human monocytes to dendritic cells

Smoking and the outcome of infection

Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team

Development of a nucleocapsid-based human coronavirus immunoassay and estimates of individuals exposed to coronavirus in a U.S. metropolitan population

Clinical characteristics of 2019 novel coronavirus infection in China

Upper airway gene expression differentiates COVID-19 from other acute respiratory illnesses and reveals suppression of innate immune responses by SARS-CoV-2

COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis

The effect of azithromycin on the maturation and function of murine bone marrow-derived dendritic cells

Genomic atlas of the human plasma proteome

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

Determining cell type abundance and expression from bulk tissues with digital cytometry

SCANNER: A Web Resource for Annotation, Visualization and Sharing of Single Cell RNA-seq Data

The Cancer Genome Atlas Pan-Cancer analysis project

Molecular signature of smoking in human lung tissues

The transcriptional landscape and mutational profile of lung adenocarcinoma

Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival

Cigarette Smoking Induces Changes in Airway Epithelial Expression of Genes Associated with Monogenic Lung Disorders

Threshold of biologic responses of the small airway epithelium to low levels of tobacco smoke

Down-regulation of the notch pathway in human airway epithelium in association with smoking and chronic obstructive pulmonary disease

Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

Bulk tissue cell type deconvolution with multi-subject single-cell expression reference

Late-onset moderate to severe acute respiratory distress syndrome is associated with shorter survival and higher mortality: a two-stage association study

STAR: ultrafast universal RNA-seq aligner

featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

Qualimap: evaluating next-generation sequencing alignment data

bcbioRNASeq: R package for bcbio RNA-seq analysis

voom: Precision weights unlock linear model analysis tools for RNA-seq read counts

Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution

Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis

scRNA-seq assessment of the human lung, spleen, and esophagus tissue stability after cold preservation

Comprehensive Integration of Single-Cell Data

Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19

Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage

The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells

Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression

Tobacco smoking induces changes in true DNA methylation, hydroxymethylation and gene expression in bronchoalveolar lavage cells

DNA methylation profiling in peripheral lung tissues of smokers and patients with COPD

Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

KEGG as a reference resource for gene and protein annotation

Cytoscape: a software environment for integrated models of biomolecular interaction networks

Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data

Local sequence and sequencing depth dependent accuracy of RNA-seq reads

Characterizing noise structure in single-cell RNA-seq distinguishes genuine from technical stochastic allelic expression

Normalization, testing, and false discovery rate estimation for RNAsequencing data

A Probabilistic Programming Language

Bayesian estimation supersedes the t test

PhenoScanner V2: an expanded tool for searching human genotypephenotype associations

Mapping the genome to the phenome through the transcriptome

The Genotype-Tissue Expression (GTEx) project

The MR-Base platform supports systematic causal inference across the human phenome